DE60031965D1 - Hochsensitiver nachweis von biomolekülen mittels "phage display" - Google Patents

Hochsensitiver nachweis von biomolekülen mittels "phage display"

Info

Publication number
DE60031965D1
DE60031965D1 DE60031965T DE60031965T DE60031965D1 DE 60031965 D1 DE60031965 D1 DE 60031965D1 DE 60031965 T DE60031965 T DE 60031965T DE 60031965 T DE60031965 T DE 60031965T DE 60031965 D1 DE60031965 D1 DE 60031965D1
Authority
DE
Germany
Prior art keywords
phage
biomolecules
target biomolecule
phage display
highly sensitive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60031965T
Other languages
German (de)
English (en)
Inventor
R Merril
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE60031965D1 publication Critical patent/DE60031965D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/682—Signal amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60031965T 1999-04-14 2000-04-13 Hochsensitiver nachweis von biomolekülen mittels "phage display" Expired - Lifetime DE60031965D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12921599P 1999-04-14 1999-04-14
PCT/US2000/010146 WO2000061790A1 (en) 1999-04-14 2000-04-13 High sensitivity phage display biomolecule detection

Publications (1)

Publication Number Publication Date
DE60031965D1 true DE60031965D1 (de) 2007-01-04

Family

ID=22438929

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60031965T Expired - Lifetime DE60031965D1 (de) 1999-04-14 2000-04-13 Hochsensitiver nachweis von biomolekülen mittels "phage display"

Country Status (8)

Country Link
US (1) US6740492B2 (enExample)
EP (1) EP1169473B1 (enExample)
JP (1) JP2002541818A (enExample)
AT (1) ATE346162T1 (enExample)
AU (1) AU778776B2 (enExample)
CA (1) CA2368875A1 (enExample)
DE (1) DE60031965D1 (enExample)
WO (1) WO2000061790A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2360282A (en) * 2000-03-17 2001-09-19 Bioinvent Int Ab Making and using micro-arrays of biological materials
WO2003010198A1 (en) * 2001-07-26 2003-02-06 Kenton Srl Identification of specific tumour antigens by selection of cdna libraries with sera and use of said antigens in diagnostic techniques
WO2003011902A1 (en) * 2001-07-27 2003-02-13 Kenton S.R.L. Identification of specific tumour antigens by selection of cdna libraries with sera
ES2301818T3 (es) * 2002-09-18 2008-07-01 The Trustees Of The University Of Pennsylvania Composiciones, procedimientos y kits para la deteccion de un antigeno sobre una celula y en una mezcla bilogica.
GB0304832D0 (en) * 2003-03-04 2003-04-09 Secr Defence Assay method
EP1853696B1 (en) * 2005-02-24 2019-04-17 Life Technologies (Israel) Ltd. Electro-blotting devices, systems, and kits, and methods for their use
US20080193917A1 (en) 2005-05-27 2008-08-14 David Alexander Schofield Biological Detection System and Method
US8066866B2 (en) * 2005-10-17 2011-11-29 Lifescan, Inc. Methods for measuring physiological fluids
WO2007064462A1 (en) * 2005-11-29 2007-06-07 The Trustees Of The University Of Pennsylvania Phage particle diagnostic reagents
WO2010006318A2 (en) * 2008-07-11 2010-01-14 Life Technologies Corporation Electrophoretically enhanced detection of analytes on a solid support
USD738527S1 (en) 2013-05-28 2015-09-08 Life Technologies Corporation Electroblotting apparatus
TWI570243B (zh) 2015-11-03 2017-02-11 國立清華大學 噬菌體之篩選裝置及方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
GB9104411D0 (en) * 1991-03-01 1991-04-17 Elchrom Limited Improvement of gel composition in gels for submerged gel electrophoresis
BE1006312A3 (fr) * 1991-11-29 1994-07-19 Univ Catholique Louvain Procede de selection de microorganismes recombinants comportant a leur surface au moins une molecule a activite enzymatique.
US5679510A (en) * 1993-04-27 1997-10-21 Hybridon, Inc. Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support
US5650267A (en) * 1993-04-27 1997-07-22 Symbiotech, Inc. Method of detecting compounds utilizing genetically modified lambdoid bacteriophage
US6027877A (en) * 1993-11-04 2000-02-22 Gene Check, Inc. Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, purification of amplified DNA samples and allele identification
US5702892A (en) * 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries
IL114149A0 (en) * 1995-06-14 1995-10-31 Yeda Res & Dev Modified avidin and streptavidin molecules and use thereof
JP2000502896A (ja) * 1995-12-15 2000-03-14 ファルマシア・アンド・アップジョン・カンパニー 病気の状態に対する治療標的およびその中和抗体様分子の同時検出法
CA2267139A1 (en) * 1996-10-08 1998-04-16 Ton Logtenberg Methods and means for selecting peptides and proteins having specific affinity for a target

Also Published As

Publication number Publication date
US6740492B2 (en) 2004-05-25
WO2000061790A1 (en) 2000-10-19
ATE346162T1 (de) 2006-12-15
AU4461200A (en) 2000-11-14
EP1169473B1 (en) 2006-11-22
JP2002541818A (ja) 2002-12-10
CA2368875A1 (en) 2000-10-19
US20020110806A1 (en) 2002-08-15
AU778776B2 (en) 2004-12-23
EP1169473A1 (en) 2002-01-09

Similar Documents

Publication Publication Date Title
DE60031965D1 (de) Hochsensitiver nachweis von biomolekülen mittels "phage display"
ATE421584T1 (de) Cpg rezeptor (cpg-r) und darauf bezogene methoden
ATE322558T1 (de) Sensible und multiplexe diagnostische tests zur proteinanalyse
BR0011849A (pt) Anticorpos enxertados lm609 melhorados
PT749325E (pt) Mpleculas biespecificas possuindo utilidades clinicas
ATE397661T1 (de) Bindungsdomänen des delta-proteins
ATE336578T1 (de) Nukleinsäurebindungsproteine
DE69433406T2 (de) Antikörper gegen cd40
DE69835143D1 (de) Selektion von proteinen mittels rns-protein fusionen
HK1046427A1 (zh) 使用atp结合盒式蛋白质输送器增加胆固醇溢出和提高hdl水平的成分与方法
ATE441711T1 (de) Peptide fähig die dimerisierung von c-jun zu inhibieren
ATE446511T1 (de) Neue fusionsproteine und molekulare bindungsassays
ATE310812T1 (de) Derivate von zinkfingerproteinen und methoden
DE69831083D1 (de) Reprimiertes trans-aktivatorsystem zur charakterisierung von protein-protein interaktionen
WO2003001863A3 (en) Novel endothelially expressed dnas and proteins, and their use
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
ATE389018T1 (de) Cx3c chemokin-gene von säugetieren
TR200003624T2 (tr) Yeni poli(ADP-RİBOZ) polimeraz-genleri
DE602004016906D1 (de) Reagenz zum Nachweis von anti-Phospholipid Antikörper
DK1180138T3 (da) Polynukleotidmotor, motorsystem, fremstilling og anvendelse deraf
DE60032201D1 (de) Apoptin bindendes Protein
WO2001072825A3 (en) Apoptin-associating protein
EP1497320A4 (en) NEW GENE EXPRESSED IN PROSTATE CANCER AND USE TECHNIQUES
AU8382701A (en) Method for identifying medically valuable active substances
DE60039192D1 (de) Antikörper gegen subersäure-crosslinker und ihre anwendung

Legal Events

Date Code Title Description
8332 No legal effect for de